Research Article

Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

Table 1

Characteristics of all studies included in the meta-analysis.

StudyRegimenNo. of patientsAge (years)Duration#OutcomesJadad
TreatmentControl

Cao et al. [12]Tongluo Huaxian granules + PDNPDN30/3060.27/61.546 MVC%, TLC%2
Dong [13]Kangxian Shufei granules + PDNPDN33/3359.11/57.73 MDLCO%, PO2, FEV1%, FVC%1
Fan et al. [14]Kechuanting granulesPDN32/3154.11/53.036 MFEV1%, FEV1/FVC,1
Tan and Li [15]Shuizhi Tongluo capsule + PDNPDN31/3161.1/63.673 MDLCO%, PO21
Wang et al. [16]Yangyin Yiqi MisturePDN34/3066.07/63.136 MDLCO%, FEV1%, FVC%,2
Weng and Ma [17]Qingjin decoction + PDNPDN42/4252.66/53.336 MPO2, FEV1%,2
Chen et al. [18]Huaxian Pogu formula + PDNPDN25/2563/653 MVC%, DLCO%, TLC%, PO21
Fan et al. [19]Feixiantong decoctionNAC22/2160.98/65.1212 WVC%, DLCO%, TLC%2
Feng et al. [20]Feixiankang granules + PDNPDN30/306 MDLCO%, PO21
Gan et al. [21]Huaxian decoction + PDNPDN26/2763.2/64.53 MDLCO2
Fan et al. [22]Feitong oral liquid (high dose)PDN73/6559.01/58.273 MDLCO%, TLC%, PO2, 6MWD5
Fan et al. [22]Feitong oral liquid (low dose)PDN66/6557.38/58.273 MDLCO%, TLC%, PO2, 6MWD5
Xu et al. [23]Bufei Yishen Huoxue decoction + PDNPDN35/3552.32/51.5112 WDLCO%, PO2, FVC%,3
Chen [24]Danhong injection + PDNPDN45/4550.2/49.512 WDLCO2
Li et al. [25]FeibitongfangPDN23/2259.97/64.5912 WVC%, TLC%, PO22
Yan et al. [26]Buyang Huanwu decoction + NACNAC60/6063.5/63.46 MDLCO%, PO2, FEV1%2
Li et al. [27]Yangyin Yifei Tongluo WanNAC34/3058.23/59.983 MVC%, DLCO%, TLC%2
Liu et al. [28]Xuefu Zhuyu capsule + NACNAC18/1618 MDLCO%, TLC%, PO2, FVC%, 6MWD2
Song [29]Xuefu Zhuyu decoction + PDNPDN48/4862.1/63.273 MFEV1%, FVC%, SGRQ2
Sun et al. [30]Danhong injection + EDED35/3548.2/50.812 WDLCO, PO22
Yan [31]Danhong injection + PDNPDN34/3452.3/53.512 WDLCO1
Hu et al. [32]Yiqi Huayu Tongluo decoction + PDNPDN40/4053.87/54.1912 WDLCO, PO2, SGRQ2
Wang et al. [33]Wenyang Huayu decoction + NACNAC43/373 MVC%, DLCO%, TLC%,1
Zhao and Wu [34]Danhong Injection + NACNAC40/4062.3/62.812 WDLCO, PO2, FEV1/FVC1
Han et al. [35]Pingfeng Shengmai powder + PDNPDN47/4759.23/58.643 MVC%, DLCO%, TLC%, PO21
Hu [36]Pingfeng Shengmai powder + PDNPDN45/4456.21/56.686 MFEV1%, FVC%, 6MWD1
Li et al. [37]Peiyuan Huoxue decoction + PDNPDN42/4259.4/59.86 MFEV1/FVC1
Miao et al. [38]Bushen Tongluo decoctionNAC28/2762.36/65.6812 WVC%, DLCO%, 6MWD, SGRQ2
Wang [39]Xuefu Zhuyu decoction + PDNPDN162/16260.6/61.324 WFVC%2
Xie and Tong [40]Yangyin Yiqi Misture + DXMDXM45/453 MFEV1/FVC, 6MWD, SGRQ2
Xin and Feng [41]Erjiaxiaozheng decoctionNAC25/2465.68/65.886 M6MWD, SGRQ1
Yuan et al. [42]Bufei Yishen Huoxue Misture + DXMDXM39/3968.56/69.613 MFEV1%, FEV1/FVC, 6MWD, SGRQ2
Cui et.al. [43]Fuzheng Tixie Souluo decoctionPlacebo30/3163.9/62.6112 WVC%, DLCO%, TLC%, FEV1%, FVC%, SGRQ4
Deng and Wang [44]Huangqi Taohong decoction + PDNPDN59/5964.06/63.213 MDLCO%, PO2, FVC%2
Feng and Sun [45]Yifei Tongluo recipe + NACNAC31/3161/62.36 MDLCO, 6MWD2
Fu and Lu [46]Loubei Lengshu decoctionPDN50/503 MDLCO%, TLC%2
Gu [47]Qishufeixian decoction + PFDPFD30/3062.3/63.86 MFEV1%, FEV1/FVC, FVC%, SGRQ2
Peng et al. [48]Qigui recipe + PDNPDN25/2558.96/59.812 W6MWD, SGRQ3
Wu [49]Danhong injection + PDNPDN30/3061.56/61.812 WDLCO, PO22
Xi and Qin [50]Huaxian Tongluo decoction + NACNAC30/3065.11/64.283 MVC%, DLCO%, TLC%, PO2, 6WMD, SGRQ2
Zhao et al. [51]Fuzheng Huaxian formulaNAC30/2458/593 MDLCO%, FVC%, 6MWD, SGRQ3

Treatment/control; #M = months, W = weeks; 6MWD: 6-minute walking distance; SGRQ: St. George’s respiratory questionnaire; VC: vital capacity; FEV1: forced expiratory volume in one second; TLC: total lung capacity; FVC: forced vital capacity; DLCO: diffusion capacity of the lung for carbon monoxide; NAC: N-acetylcysteine; PDN: prednisone; DXM: dexamethasone; PFD: pirfenidone; ED: edaravone; % indicates the percentage of measured value to predicted value.